SCHEMBL6799581

SCHEMBL6799581

COC(=O)[C@@H](C)NS(=O)(=O)c1ccc(Sc2ccc(C)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.51
HSD17B10 Q99714 2/20 0.51
HTT P42858 1/20 0.51
ALDH1A1 P00352 4/20 0.50
MMP13 P45452 2/20 0.50
KDM4E B2RXH2 1/20 0.50
HPGD P15428 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.48
MMP2 P08253 2/20 0.47
MMP9 P14780 2/20 0.47
MMP1 P03956 1/20 0.47
MMP3 P08254 1/20 0.47
MMP7 P09237 1/20 0.47
CA9 Q16790 3/20 0.46
CA12 O43570 2/20 0.46
CA14 Q9ULX7 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
KCNQ1 P51787 1/20 0.45
SLC1A3 P43003 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7138463 0.91 TSHR (0.58) TSHRHSD17B10HTTALDH1A1MMP13
SCHEMBL25269775 0.91 TSHR (0.58) TSHRHSD17B10HTTALDH1A1MMP13
SCHEMBL7889040 0.91 TSHR (0.58) TSHRHSD17B10HTTALDH1A1MMP13
SCHEMBL6793899 0.86 ADAMTS4 (0.60) TSHRHSD17B10HTTALDH1A1MMP13
SCHEMBL8446641 0.83 MMP9 (0.64) TSHRHSD17B10HTTALDH1A1MMP13
SCHEMBL19404003 0.78 HTT (0.54) TSHRHSD17B10HTTALDH1A1MMP13
SCHEMBL6329696 0.78 HSD17B10 (0.60) TSHRHSD17B10HTTALDH1A1MMP13
SCHEMBL29541363 0.78 HSD17B10 (0.60) TSHRHSD17B10HTTALDH1A1MMP13
SCHEMBL6329698 0.78 HSD17B10 (0.60) TSHRHSD17B10HTTALDH1A1MMP13
SCHEMBL6800772 0.78 MMP2 (0.77) MMP13MMP2MMP9MMP1MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040034071-A1 Thioaryl sulfonamide hydroxamic acid compounds PHARMACIA CORPORATION 2004-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034071-A1 Thioaryl sulfonamide hydroxamic acid compounds MMP10, MMP1, MMP3 TSHR 1871/4885HSD17B10 578/4885HTT 535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.